View Older Stories View More Recent Stories

Oct 23, 2025 07:00AM Moderna to Host Investor Event - Analyst Day
Oct 22, 2025 04:05PM Moderna CMV vaccine fails phase 3 trial, development discontinued
Oct 22, 2025 04:05PM Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint
Oct 19, 2025 08:00AM Moderna Highlights Seasonal Flu and H5 Pandemic Flu Candidates at IDWeek 2025
Oct 16, 2025 07:00AM Moderna to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
Oct 13, 2025 05:08AM Moderna reports early cancer therapy data at medical conference
Oct 12, 2025 06:05PM Moderna Presents Promising Early Data for Its Investigational Cancer Antigen Therapy at the 2025 European Society for Medical Oncology Congress
Sep 24, 2025 07:01PM Moderna Opens State-of-the-Art Manufacturing and R&D Facility in the UK
Sep 23, 2025 07:12AM Moderna vaccine shows strong immune response against LP.8.1 variant
Sep 23, 2025 07:00AM Moderna Announces mNEXSPIKE Generates Strong Immune Response Against LP.8.1 Variant in Humans
Sep 16, 2025 06:12AM Moderna COVID-19 vaccine shows 8-fold antibody increase against LP.8.1 variant
Sep 16, 2025 06:00AM Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans
Sep 2, 2025 07:07AM Moderna to present rare disease data at metabolism congress
Sep 2, 2025 07:00AM Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism
Aug 27, 2025 02:02PM Moderna receives FDA approval for updated COVID-19 vaccines
Aug 27, 2025 01:24PM Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2
Aug 21, 2025 07:00AM Moderna to Present at Upcoming Conferences in September 2025
Aug 1, 2025 07:00AM Moderna Reports Second Quarter 2025 Financial Results and Provides Business Updates
Aug 1, 2025 06:00AM UK Court of Appeal Confirms Moderna’s EP'949 Patent is Valid and Infringed by Pfizer/BioNTech
Jul 30, 2025 04:12PM Moderna receives European approval for updated COVID-19 vaccine
Jul 30, 2025 04:05PM Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1
Jul 28, 2025 07:12AM Moderna to present cancer therapy data at ESMO Congress in October
Jul 28, 2025 07:00AM Moderna Announces Data to be Presented at ESMO Congress 2025
Jul 25, 2025 08:52AM Moderna receives positive EMA Committee opinion for COVID-19 mRNA Vaccine targeting the SARS-CoV-2 Variant LP.8.1
Jul 25, 2025 08:45AM EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-CoV-2 Variant LP.8.1
Jun 30, 2025 07:00AM Moderna (MRNA) Announces Positive Phase 3 Results for Seasonal Influenza Vaccine
Jun 30, 2025 07:00AM Moderna Announces Positive Phase 3 Results for Seasonal Influenza Vaccine
Jun 12, 2025 07:25PM Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease
Jun 11, 2025 07:00AM Moderna to Present at Upcoming Barclays Speaking the Science Call Series on June 16, 2025
May 31, 2025 12:16AM Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
May 28, 2025 06:01PM Moderna (MRNA) announces positive interim data from phase 1/2 study on flu vaccine
May 28, 2025 06:00PM Moderna Announces Update on Investigational Pandemic Influenza Program
May 27, 2025 07:00AM Moderna to Present at Upcoming Conferences in June 2025
May 23, 2025 04:09PM Moderna (MRNA) files FDA application for Spikevax formula
May 23, 2025 04:05PM Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine
May 21, 2025 07:05AM Moderna (MRNA) has voluntarily withdrawn the pending BLA for mRNA-1083
May 21, 2025 07:00AM Moderna Provides Update on BLA Submission for Combination Vaccine Against Influenza and COVID-19
May 8, 2025 07:00AM Moderna to Present at Upcoming Bernstein's 41st Annual Strategic Decisions Conference (SDC) on May 29, 2025
May 1, 2025 06:30AM Moderna Reports First Quarter 2025 Financial Results and Provides Business Updates
Apr 10, 2025 07:00AM Moderna to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
Apr 7, 2025 07:02AM Moderna (MRNA) to Showcase Extensive Infectious Disease Research
Apr 7, 2025 07:00AM Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025
Mar 31, 2025 07:06AM Moderna (MRNA) Receives Australian Therapeutic Goods Administration Approval for RSV Vaccine for Older Adults
Mar 31, 2025 07:00AM Moderna Receives Australian Therapeutic Goods Administration Approval for RSV Vaccine for Older Adults
Feb 25, 2025 07:00AM Moderna to Present at Upcoming Conferences in March 2025
Feb 14, 2025 06:28AM Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
Jan 29, 2025 07:00AM Moderna to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, February 14, 2025
Jan 24, 2025 06:31AM Moderna (MRNA) Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union
Jan 24, 2025 06:30AM Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union
Jan 17, 2025 04:28PM Moderna Announces Updates on Pandemic Influenza Program
View More Recent Stories View Older Stories